An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
J. Surey*, H. R. Stagg, T. A. Yates, M. Lipman, Peter White, Andre Charlett, L. Muñoz, L. Gosce, M. X. Rangaka, M. Francis, V. Hack, H. Kunst, I. Abubakar
Research output: Contribution to journal › Article › peer-review
9Citations
(Scopus)
Fingerprint
Dive into the research topics of 'An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study'. Together they form a unique fingerprint.